Uqora Maximum Uti Pain Relief Tablet
Product Images NDC 73712-114

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Uqora Maximum Uti Pain Relief (NDC 73712-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bonafide Health, Llc Dba Uqora, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Carton 12 Ct)

This is a product information sheet for a powerful urinary pain relief medication in a fast-acting form. It provides targeted relief for pain and discomfort, specifically designed to address urinary tract challenges. The product contains 99.5 mg of Phenazopyridine Hydrochloride and is formulated for urgent pain relief needs. The text also mentions a urinary tract drink mix designed for women facing urinary tract challenges. The medication is suitable for individuals above 12 years old and should be shaken before use, with specific dosage instructions provided. The product is distributed by a company located in San Diego, CA.*

FDA Label Image

2 (Carton 24 Ct)

This text appears to be a description of a product related to urinary health expert Uqora. It mentions science-backed formulas for urinary tract health, UTI pain relief, and urinary tract drink mixes. The product is designed for women with recurrent urinary tract challenges and claims to provide fast, targeted relief for symptoms like burning, pain, and discomfort. The text also includes drug facts, warnings, directions for use, and contact information for the company.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.